THE COST OF TREATMENT FAILURE: RESOURCE USE AND COSTS INCURRED BY HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS WHO DO OR DO NOT ACHIEVE SUSTAINED VIROLOGICAL RESPONSE TO THERAPY

BACKX, M., LEWSZUK, A., & WHITE, J.R.. (2014). THE COST OF TREATMENT FAILURE: RESOURCE USE AND COSTS INCURRED BY HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS WHO DO OR DO NOT ACHIEVE SUSTAINED VIROLOGICAL RESPONSE TO THERAPY. JOURNAL OF VIRAL HEPATITIS, 21(3), 208-215. SID. https://sid.ir/paper/670753/en

BACKX M., LEWSZUK A., WHITE J.R.. THE COST OF TREATMENT FAILURE: RESOURCE USE AND COSTS INCURRED BY HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS WHO DO OR DO NOT ACHIEVE SUSTAINED VIROLOGICAL RESPONSE TO THERAPY. JOURNAL OF VIRAL HEPATITIS[Internet]. 2014;21(3):208-215. Available from: https://sid.ir/paper/670753/en

M. BACKX, A. LEWSZUK, and J.R. WHITE, “THE COST OF TREATMENT FAILURE: RESOURCE USE AND COSTS INCURRED BY HEPATITIS C VIRUS GENOTYPE 1-INFECTED PATIENTS WHO DO OR DO NOT ACHIEVE SUSTAINED VIROLOGICAL RESPONSE TO THERAPY,” JOURNAL OF VIRAL HEPATITIS, vol. 21, no. 3, pp. 208–215, 2014, [Online]. Available: https://sid.ir/paper/670753/en